Huang Huang, Lai Emily, Bhavsar Shreyas, Miller Brian, Chung Jovelle, Phillips Bradly, Feng Lei, Soliz Jose Miguel, Brown Jessica
Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, USA.
Int J Anesth Clin Med. 2024 Dec;12(2):109-115. doi: 10.11648/j.ijacm.20241202.18. Epub 2024 Nov 22.
The rapidly acting opioid fentanyl commonly used in the perioperative setting, has traditionally been packaged in 100 or 250-μg vials. In September 2021, our institution implemented a change from fentanyl 100-μg vials to 50-μg preloaded syringes in our operating rooms. The objective of this study was aimed at assessing the association of the fentanyl product change on reducing medication waste and the amount of fentanyl administered during surgery.
This single-center, retrospective study entailed a review of anesthesia records from September 2020 to September 2022 of adult patients who underwent general anesthesia and received fentanyl for surgery at The University of Texas MD Anderson Cancer Center. The data set was divided into a control period (CP) using 100-μg vials and a post transition period (PT) using 50-μg preloaded syringes. The primary outcome measures were the average amounts of fentanyl used and wasted per case. Secondary outcome measures consisted of intraoperative analgesic use as well as postoperative pain scores.
Among the 33,405 cases included in this study, the mean amount of fentanyl used per surgical case was higher in the CP group than in the PT group (133μg vs. 102μg; p<0.001). Additionally, fentanyl waste occurred in a higher percentage of cases in the CP group than in the PT group (13.9% vs. 2.9%; p<0.001). We did not observe a significant difference in post-anesthesia care unit pain scores between the CP and PT groups.
Transitioning to preloaded fentanyl syringes decreased medication waste and overuse of opioids intraoperatively. Simultaneously, the transition did not adversely affect patient analgesia in the post-anesthesia care unit.
围手术期常用的速效阿片类药物芬太尼,传统上包装在100微克或250微克的小瓶中。2021年9月,我们机构在手术室将芬太尼100微克小瓶改为50微克预充式注射器。本研究的目的是评估芬太尼产品更换与减少药物浪费以及手术期间芬太尼给药量之间的关联。
这项单中心回顾性研究,对2020年9月至2022年9月在德克萨斯大学MD安德森癌症中心接受全身麻醉并在手术中使用芬太尼的成年患者的麻醉记录进行了回顾。数据集分为使用100微克小瓶的对照期(CP)和使用50微克预充式注射器的过渡期后(PT)。主要观察指标是每例患者芬太尼的平均使用量和浪费量。次要观察指标包括术中镇痛药物的使用以及术后疼痛评分。
在本研究纳入的33405例病例中,CP组每例手术的芬太尼平均使用量高于PT组(133微克对102微克;p<0.001)。此外,CP组芬太尼浪费的病例百分比高于PT组(13.9%对2.9%;p<0.001)。我们未观察到CP组和PT组在麻醉后护理单元疼痛评分上有显著差异。
改用预充式芬太尼注射器可减少术中药物浪费和阿片类药物的过度使用。同时,这种转变对麻醉后护理单元的患者镇痛没有不利影响。